Transesophageal echocardiograpy in patients with persistent atrial fibrillation undergoing electrical cardioversion on new oral anticoagulants: A multi center registry

International Journal of Cardiology

Volumn 184, Issue 1, 2015, Pages 283-284

  Stabile, Giuseppe ^a   Russo, Vincenzo ^b   Rapacciuolo, Antonio ^c   De Divitiis, Marcello ^d   De Simone, Antonio ^e   Solimene, Francesco ^f   D'Onofrio, Antonio ^g   Iuliano, Assunta ^a   Maresca, Gennaro ^c   Esposito, Francesca ^c   La Rocca, Vincenzo ^e   Schillaci, Vincenzo ^f   De Crescenzo, Ilaria ^d   Losi, Maria Angela ^c   Librera, Mariateresa ^a  

^a Laboratorio di Elettrofisiologia Clinica Mediterranea   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d Osp Pellegrini   (Italy)

^e Clinica San Michele   (Italy)

^f Clinica Montevergine   (Italy)

^g MONALDI HOSPITAL   (Italy)

Author keywords

Atrial fibrillation; Electrical cardioversion; New oral anticoagulants

Indexed keywords

ANTICOAGULANT AGENT; ANTIVITAMIN K; APIXABAN; DABIGATRAN; RIVAROXABAN;

AGED; ATRIAL FIBRILLATION; CARDIOVASCULAR PARAMETERS; CARDIOVERSION; CEREBROVASCULAR ACCIDENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HEART ATRIUM THROMBOSIS; HEART LEFT ATRIAL DIAMETER; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; THROMBOSIS PREVENTION; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TREATMENT DURATION; CLINICAL TRIAL; ECHOGRAPHY; HEART ATRIUM; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PROCEDURES; REGISTER; THROMBOSIS;

ADMINISTRATION, ORAL; AGED; ANTICOAGULANTS; ATRIAL FIBRILLATION; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; ELECTRIC COUNTERSHOCK; FEMALE; HEART ATRIA; HUMANS; MALE; MIDDLE AGED; REGISTRIES; THROMBOSIS;

EID: 84933573733     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2015.02.075     Document Type: Article

References (10)

1. A.J. Camm, P. Kirchhof, G.Y. Lip, U. Schotten, et al., Guidelines for themanagement of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC), Eur. Heart J. 31 (2010) 2369-2429.
2. C.T. January, L.S. Wann, J.S. Alpert, et al., 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society, Circulation 130 (2014) 2071-2104.
3. A.L. Klein, R.D. Murray, R.A. Grimm, Role of transesophageal echocardiographyguided cardioversion of patients with atrial fibrillation, J. Am. Coll. Cardiol. 37 (2001) 691-704.
4. R. Nagarakanti, M.D. Ezekowitz, J. Oldgren, et al., Dabigatran versus warfarin in patients with atrial fibrillation: An analysis of patients undergoing cardioversion, Circulation 123 (2011) 131-136.
5. J.P. Piccini, S.R. Stevens, Y. Lokhnygina, et al., Outcomes following cardioversion and atrial fibrillation ablation in patients treated with rivaroxaban and warfarin in the ROCKET AF trial, J. Am. Coll. Cardiol. 61 (2013) 1998-2006.
6. G. Flaker, R.D. Lopes, S.M. Al Khatib, et al., Efficacy and safety of apixaban in patients after cardioversion for atrial fibrillation: Insights from the ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation), J. Am. Coll. Cardiol. 63 (2014) 1082-1087.
7. R. Cappato, M.D. Ezekowitz, A.L. Klein, et al., on behalf of the X-VeRT Investigators, Rivaroxaban vs. vitamin K antagonists for cardioversion in atrial fibrillation, Eur. Heart J. 35 (2014) 3346-3355.
8. A. Yadlapati, C. Groh, R. Passman, Safety of short-term use of dabigatran or rivaroxaban for direct-current cardioversion in patients with atrial fibrillation and atrial flutter, Am. J. Cardiol. 113 (2014) 1362-1363.
9. S. Shore, E.P. Carey, M.P. Turakhia, et al., Adherence to dabigatran therapy and longitudinal patient outcomes: Insights from the veterans health administration, Am. Heart J. 167 (6) (2014 Jun) 810-817.
10. H. Heidbuchel, P. Verhamme, M. Alings, et al., European Heart Rhythm Association, European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation, Europace 15 (5) (May 2013) 625-651.